Figure 6. Clinical efficacy over time as measured by mean (standard error).
(A–D) ESSDAI total score, unstimulated salivary flow, stimulated salivary flow, and ESSPRI total score (completer population, n = 60). *N = 15 at week 12. †N = 15 at week 36. ‡N = 15 at weeks 36 and 68. §N = 16 at week 52. ESSDAI, EULAR Sjögren’s syndrome disease activity index; ESSPRI, EULAR Sjögren’s Syndrome Patient Reported Index.